TMCnet - World's Largest Communications and Technology Community



Trilliant Health Announces Major Growth Investment from Primus Capital
[November 19, 2019]

Trilliant Health Announces Major Growth Investment from Primus Capital

Trilliant Health announced today a major growth investment by Primus Capital (Primus). Trilliant (News - Alert) is an analytics company that empowers healthcare providers to create and execute data-driven strategies to maximize revenue and market share growth. The investment by Primus will accelerate Trilliant's rapid rise as the preferred revenue growth solution used by hospitals and healthcare providers.

"Trilliant Health is transforming the way healthcare systems approach growth," said Phil Molner, Managing Partner of Primus. "By applying advanced analytics to comprehensive claims data and consumer data, Trilliant provides tremendous value to its clients by offering a unique set of solutions to grow profitable revenue. We are excited to partner with the team to build upon their successes to date."

"We could not have found a better partner than Primus," said Hal Andrews, President & CEO of Trilliant Health. "In the current environment of rising expenses, relentless reimbursement cuts, and growing competition, healthcare providers need proactive strategies to find the most efficient and effective solutions for growth more than ever. Our analytic insights make Trilliant the ideal growth partner for health systems and other healthcare providers. Having the support of Primus allows us to accelerate our product development to deliver additional value to our existing customers and expand our customer roster."

Trilliant will use the funding to continue building its data science and technology teams to enhance the capabilities of its analytics platform. The Trilliant Analytics Platfom uses advanced data science methodologies to combine claims data, household data, and user-generated data from digital marketing campaigns to support healthcare systems around strategy, consumer loyalty, site selection, M&A, payer negotiations, physician alignment, and marketing. Today, the company works with over 70 healthcare systems across the nation to build and execute on their growth strategies.

Primus joins existing investors who also participated in the recapitalization, including Providence Ventures, Martin Ventures, Noro-Moseley Partners, and Nashville Capital Network.

As a result of the transaction, Jeff Stolte, Senior Partner of Providence Ventures, has joined the Trilliant Board of Directors. "Healthcare providers navigate complex strategic decisions every day, and Trilliant helps Providence St. Joseph Health do so more effectively with its advanced, market-leading analytics capabilities. Providence Ventures' decision to invest in Trilliant was heavily informed by our operating colleagues' positive feedback during their vendor selection process, which is emblematic of our investment approach," added Stolte.

About Trilliant Health

Trilliant Health is an analytics and data science company that empowers intelligent patient acquisition. By synthesizing all-payer claims, household, and patient-generated data, Trilliant Health provides a comprehensive view into market dynamics that enables healthcare providers to find the most efficient and effective solutions for growth in their markets. For more information, please visit

About Primus Capital

Primus Capital is a growth-oriented private equity firm focused on investing in leading healthcare, software, and technology-enabled services companies. Primus is currently managing Primus Capital Fund VIII, building on a long history of successful investing. Primus has invested in over 130 companies, partnering with exceptional management teams to accelerate growth and create shareholder value by applying our industry knowledge, financial resources, and investment experience. For more about Primus, visit

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2019 Technology Marketing Corporation. All rights reserved | Privacy Policy